These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21732137)

  • 21. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.
    Pilati P; Mocellin S; Bertazza L; Galdi F; Briarava M; Mammano E; Tessari E; Zavagno G; Nitti D
    Ann Surg Oncol; 2012 Feb; 19(2):402-8. PubMed ID: 22071867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.
    Bessa X; Elizalde JI; Boix L; Piñol V; Lacy AM; Saló J; Piqué JM; Castells A
    Gastroenterology; 2001 Apr; 120(5):1084-92. PubMed ID: 11266372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
    Katsuno H; Zacharakis E; Aziz O; Rao C; Deeba S; Paraskeva P; Ziprin P; Athanasiou T; Darzi A
    Ann Surg Oncol; 2008 Nov; 15(11):3083-91. PubMed ID: 18787906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
    Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.
    Findeisen P; Röckel M; Nees M; Röder C; Kienle P; Von Knebel Doeberitz M; Kalthoff H; Neumaier M
    Int J Oncol; 2008 Nov; 33(5):1001-10. PubMed ID: 18949363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA; Carusone L; Bhattacharya S
    In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.
    Sieuwerts AM; Kraan J; Bolt-de Vries J; van der Spoel P; Mostert B; Martens JW; Gratama JW; Sleijfer S; Foekens JA
    Breast Cancer Res Treat; 2009 Dec; 118(3):455-68. PubMed ID: 19115104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
    De Luca A; Pignata S; Casamassimi A; D'Antonio A; Gridelli C; Rossi A; Cremona F; Parisi V; De Matteis A; Normanno N
    Clin Cancer Res; 2000 Apr; 6(4):1439-44. PubMed ID: 10778975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
    Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
    Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
    Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
    Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global gene expression profiling of circulating tumor cells.
    Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.
    Ferroni P; Roselli M; Spila A; D'Alessandro R; Portarena I; Mariotti S; Palmirotta R; Buonomo O; Petrella G; Guadagni F
    Cancer; 2010 Jun; 116(12):2913-21. PubMed ID: 20336782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of the detection of peripheral blood CEACAM5mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancer.
    Vardakis N; Messaritakis I; Papadaki C; Agoglossakis G; Sfakianaki M; Saridaki Z; Apostolaki S; Koutroubakis I; Perraki M; Hatzidaki D; Mavroudis D; Georgoulias V; Souglakos J
    Clin Cancer Res; 2011 Jan; 17(1):165-73. PubMed ID: 21071514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system.
    Andreopoulou E; Yang LY; Rangel KM; Reuben JM; Hsu L; Krishnamurthy S; Valero V; Fritsche HA; Cristofanilli M
    Int J Cancer; 2012 Apr; 130(7):1590-7. PubMed ID: 21469140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
    Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H
    Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
    de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
    Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.
    Ko Y; Klinz M; Totzke G; Gouni-Berthold I; Sachinidis A; Vetter H
    Clin Cancer Res; 1998 Sep; 4(9):2141-6. PubMed ID: 9748132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.